Skip to content
HowShorted

Syndax Pharmaceuticals Inc short interest in 2026

In 2026, Syndax Pharmaceuticals Inc's disclosed short interest ran from 25.71% of shares outstanding on 15 Jan 2026 to 23.14% on 15 Sep 2026, a change of -2.57 percentage points. The year's high was 25.71% on 15 Jan 2026 and its low 18.78% on 29 May 2026, averaging 23.93% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.86 days on 27 Feb 2026. Full history: Syndax Pharmaceuticals Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Syndax Pharmaceuticals Inc in 2026

2026 in figures

Start of year
25.71% (15 Jan 2026)
End of year
23.14% (15 Sep 2026)
Change
-2.57 pp
High
25.71% (15 Jan 2026)
Low
18.78% (29 May 2026)
Average
23.93%
Highest days to cover
19.86 (27 Feb 2026)
SEC filings marked
7

Every report in 2026

Syndax Pharmaceuticals Inc short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202625.71%16.06results (8-K)
30 Jan 202624.33%17.22
13 Feb 202625.45%17.85
27 Feb 202625.08%19.8610-K filed, results (8-K)
13 Mar 202623.57%13.48
31 Mar 202623.81%13.63
15 Apr 202624.12%15.24
30 Apr 202622.47%12.6610-Q filed, results (8-K)
15 May 202624.50%10.54
29 May 202618.78%16.02
15 Jun 202622.41%9.10
30 Jun 202624.62%8.56
15 Jul 202623.49%9.83
31 Jul 202625.38%18.58
14 Aug 202625.65%15.0310-Q filed, results (8-K)
31 Aug 202624.28%19.65
15 Sep 202623.14%14.73

See also: Syndax Pharmaceuticals Inc's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.